Device Trial Radar · NCT04064229
ivWatch Sensor: Device Validation for Infiltrated Tissues
Last checked: Nov 20, 2026Latest source record: Jun 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99
Actual
Start
Apr 3, 2019
Primary completion
Apr 9, 2019
Study completion Apr 9, 2019
Sponsor
- Lead sponsor
- ivWatch, LLCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 21, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A single arm trial consisting of 98 adult volunteers to assess the safety and efficacy of ivWatch sensors when observing infiltrated tissues at common sites for peripheral IV therapy.
Conditions
- Infiltration of Peripheral IV Therapy
Interventions
ivWatch Model 400 with SmartTouch SensorDevice
The ivWatch Model 400 with SmartTouch Sensor monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.
ivWatch Model 400 with Fiber Optic SensorDevice
The ivWatch Model 400 with Fiber Optic Sensor monitored the site during the course of the infiltration and issued red and/or yellow notifications if an infiltration was detected.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Red Notification Sensitivity to Infiltrated TissuesTime frame: After each participant has been infiltrated, an expected average of 1 hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ivWatch, LLC
Williamsburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.